These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7070730)

  • 1. Surveillance and management of patients at high genetic risk for ovarian carcinoma.
    Lynch HT; Albano WA; Lynch JF; Lynch PM; Campbell A
    Obstet Gynecol; 1982 May; 59(5):589-96. PubMed ID: 7070730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and management strategies of hereditary ovarian cancer syndrome].
    Shen K; Lang J; Huang R
    Zhonghua Fu Chan Ke Za Zhi; 1996 Dec; 31(12):732-5. PubMed ID: 9387515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing the correct ovarian cancer syndrome.
    Trimble EL; Karlan BY; Lagasse LD; Hoskins WJ
    Obstet Gynecol; 1991 Dec; 78(6):1023-6. PubMed ID: 1945201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.
    Lynch HT; Watson P; Conway TA; Lynch JF; Slominski-Caster SM; Narod SA; Feunteun J; Lenoir G
    Arch Intern Med; 1993 Sep; 153(17):1979-87. PubMed ID: 8357282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
    Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K
    Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
    Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
    Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: first experiences with patient perceptions, surveillance behavior and acceptance of genetic testing.
    Hofferbert S; Worringen U; Backe J; Rückert EM; White K; Faller H; Grimm T; Caffier H; Chang-Claude J; Weber BH
    Genet Couns; 2000; 11(2):127-46. PubMed ID: 10893664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary ovarian cancer.
    Russo A; Calò V; Bruno L; Rizzo S; Bazan V; Di Fede G
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):28-44. PubMed ID: 18656380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
    Brunsvold AN; Wung SF; Merkle CJ
    J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary ovarian cancer: a dilemma in prognosis.
    Klein B; Lurie H; Stein M; Kuten A; Steinherz R
    Isr J Med Sci; 1992 Jan; 28(1):16-9. PubMed ID: 1733892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In cases of familial ovarian cancer, always consider the risk of breast cancer].
    Kets CM; Niermeijer MF; Massuger LF; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2004 Aug; 148(35):1709-11. PubMed ID: 15468897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management.
    Lynch HT; Riley BD; Weissman SM; Coronel SM; Kinarsky Y; Lynch JF; Shaw TG; Rubinstein WS
    Cancer; 2004 Jan; 100(1):53-64. PubMed ID: 14692024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of prophylactic oophorectomy in cancer prevention.
    Averette HE; Nguyen HN
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S38-41. PubMed ID: 7835808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary ovarian cancer: molecular genetics and clinical implications.
    Boyd J; Rubin SC
    Gynecol Oncol; 1997 Feb; 64(2):196-206. PubMed ID: 9038264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial ovarian cancer syndrome].
    Bösze P
    Orv Hetil; 1994 Feb; 135(9):459-64. PubMed ID: 8139849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
    Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
    Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
    Kuschel B; Lux MP; Goecke TO; Beckmann MW
    Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.